Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

Share Price is delayed by 15 minutes
Get Live Data
4.275    0.005 (0.12%)
Bid:
4.31
Ask:
4.40
Spread: 0.09 (2.088%)
Market Cap: £205.18m
SEE Live PriceLast checked at - London Stock Exchange

Intraday Seeing Machines Share Chart

Joint Venture created

15 Oct 2014 07:00

RNS Number : 2667U
Seeing Machines Limited
15 October 2014
 



Seeing Machines and Australian National University Sign Truefield Joint Venture

New entity created to commercialise ophthalmic-research IP

 

15 October 2014

 

Seeing Machines Limited (AIM: SEE), the AIM listed technology company with a focus on operator monitoring and intervention sensing technologies and services, is proud to announce the formation of a new joint venture, NuCoria Pty. Ltd., with The Australian National University (ANU) to commercialise TrueField Analyzer (TFA) Intellectual Property. Leveraging Seeing Machines' patented IP, technical expertise, and ANU's technology transfer & commercialisation successes, NuCoria will be dedicated to bringing revolutionary medical devices to market.

The TrueField Analyzer was originally developed collaboratively between ANU and Seeing Machines, and each of them has licensed their relevant existing intellectual property to NuCoria. NuCoria is a strategic arrangement that allows Seeing Machines to focus on core opportunities and competencies, including its alliances with Caterpillar Global Mining and TK Holdings (part of the Takata Group) and other rapidly emerging transport sector opportunities. ANU, following its own successful sale of Lithicon for A$76m, will take the lead in managing, staffing, and funding NuCoria. Seeing Machines will have an initial interest of 18% of NuCoria, will nominate a non-executive director and will receive royalties from any future licensing deals the new Company enters into.

NuCoria will become the primary vehicle for emerging ophthalmic-technology IP from ANU research centres. Professor Ted Maddess, TFA inventor and Director of the ARC Centre of Excellence in Vision Science, said: "We have been working with Seeing Machines to produce a rapid non-contact objective way of mapping the visual fields of both eyes at the same time. We have now published 17 studies showing that the new method has utility for the top three blinding diseases: glaucoma, macular degeneration and diabetic retinopathy, and also for some neurological disorders. The method continues to evolve and improve."

Ken Kroeger, CEO of Seeing Machines, said: "This is a fantastic outcome for all parties. Our company's DNA & legacy is closely tied with the ANU, hence I firmly believe that they are the right partners to move forward with this exciting technology. While the core focus of Seeing Machines is to save lives with our Driver Safety System (DSS) in the mining and road-transport industries, being able to work with strategic partners in exciting applications of our core-technology is part-and-parcel of how we operate."

Michael Cardew-Hall, ANU Pro-Vice Chancellor of Innovation and Advancement, said: "This is an exciting development in commercialisation of the TrueField Analyzer technology. The ANU has been committed to partnering with Seeing Machines in the development of the TrueField IP which was originally generated from research at the University. We believe that it has the potential to have significant benefits in the area of ophthalmology. The links between ANU and Seeing Machines are long standing, with it originally being a start up from the University itself. The NuCoria collaboration brings the expertise of Seeing Machines and ANU together to take this technology to market."

_______________________________________

 

Enquiries:

Seeing Machines Limited

www.seeingmachines.com

Ken Kroeger, Managing Director and CEO

+61 2 6103 4700

Ken.Kroeger@seeingmachines.com

James Walker, Finance Director

+61 2 6103 4700

James.Walker@seeingmachines.com

finnCap Ltd, Broker for Seeing Machines

Ed Frisby / Ben ThompsonCorporate Finance

+44 20 7220 0500

Victoria BatesCorporate Broking

Newgate Threadneedle, Investment Communications for Seeing Machines

Robyn McConnachie

 

 

Josh Royston

Tel: +44 20 7653 9852

Mob: +44 7540 706 191

r.mcconnachie@newgatethreadneedle.com

Tel: +44 20 7653 9844

Mob: +44 7789 003 223

j.royston@newgatethreadneedle.com

About Seeing Machines

Seeing Machines, (AIM: SEE), is an AIM-listed technology company that specialises in operator monitoring and intervention technologies and services. Its software and engineering services are used in products and applications that range from devices that improve driver safety and save lives to assessing trainees in simulators and simplifying the relationships between people and technology. Seeing Machines technology is used worldwide across the automotive, mining, transport and aviation industries; as well as many of the leading academic research groups and transportation authorities. Seeing Machines is headquartered in Australia, and has offices in Tucson, Arizona and Mountain View, California. The Company counts Caterpillar, Takata and Eye Tracking Inc as its partners and BHP Billiton, Freeport McMoran, Teck, Toll Holdings amongst its customers.

 

About The Australian National University

The Australian National University was established in 1946 to support the development of national unity and identity, to improve Australia's understanding of itself and its neighbours, and to contribute to economic development and social cohesion. ANU is a celebrated place of intensive research, education and policy engagement - setting the standard on issues of national and international importance. Its body of students is drawn from across the nation and around the world. ANU is a global university that consistently ranks amongst the world's finest educational institutions, and is a centre of unparalleled intellectual talent and research excellence. The University's research has been involved in the creation of a number of successful spin-off companies, including Seeing Machines, Beta Therapeutics and Lithicon.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAMIBTTMBIBBTI
Date   Source Headline
10th May 20227:00 amRNSSeeing Machines appointment with Japanese OEM
9th May 20227:00 amRNSSeeing Machines collaboration in optics technology
21st Apr 20227:00 amRNSCollaboration with leading systems supplier
20th Apr 20227:00 amRNSSeeing Machines inks additional Occula NPU licence
30th Mar 20227:00 amRNSHalf-year results and financial report
28th Feb 202211:45 amRNSDirector/PDMR Shareholding
24th Feb 20227:00 amRNSSeeing Machines, Air Ambulance Victoria contract
23rd Feb 20227:00 amRNSHalf year trading update
16th Feb 20229:00 amRNSHolding(s) in Company
24th Jan 20227:00 amRNSIIHS Implementation of New Safety Ratings
6th Jan 202212:30 pmRNSSeeing Machines & Qualcomm to demo at CES 2022
6th Jan 202210:01 amRNSAmbarella & Seeing Machines Collaboration
5th Jan 202211:02 amRNSOmniVision & Seeing Machines ASIC Collaboration
31st Dec 20217:00 amRNSWithdrawal from in-person attendance at CES 2022
23rd Dec 202110:30 amRNSIssue of Performance Rights
16th Dec 20218:30 amRNSResult of AGM
16th Dec 20217:00 amRNSLargest Driver & Occupant Monitoring System Award
15th Dec 20218:08 amRNSFY 2021 Annual Report
14th Dec 202110:30 amRNSDirector/PDMR Shareholding
13th Dec 202110:00 amRNSDirector/PDMR Shareholding
9th Dec 20219:15 amRNSDirector/PDMR Shareholding
6th Dec 202110:00 amRNSNotice of AGM
1st Dec 202112:15 pmRNSHolding(s) in Company
1st Dec 202112:00 pmRNSDirector/PDMR Shareholding
1st Dec 20217:00 amRNSTotal Voting Rights
26th Nov 202110:00 amRNSDirector/PDMR Shareholding
26th Nov 20219:48 amRNSDirector/PDMR Shareholding
24th Nov 202110:52 amRNSIssue of Equity
24th Nov 20217:00 amRNSYear End Results
23rd Nov 20217:00 amRNSResult of Fundraise
22nd Nov 20214:37 pmRNSRetail Offer via PrimaryBid
22nd Nov 20214:35 pmRNSProposed Fundraise to Raise a Minimum of US$40m
15th Nov 20217:00 amRNSCollins Aerospace & Seeing Machines Collaboration
10th Nov 20217:00 amRNSChange of Nominated Adviser
8th Nov 20217:00 amRNSBipartisan infrastructure legislation
2nd Nov 20217:00 amRNSInvestor Presentation
18th Oct 20217:37 amRNSNotice of Results
13th Oct 20217:00 amRNSSeeing Machines establishes European sales team
11th Oct 20217:00 amRNSGlobal Framework Agreement with Shell
23rd Sep 20212:00 pmRNSSeeing Machines unveils its Occula® NPU
16th Aug 20217:13 amRNSLeading software provider integrates Guardian
11th Aug 20217:00 amRNSBipartisan Senate legislation
10th Aug 20217:00 amRNSHolding(s) in Company
3rd Aug 20217:00 amRNSFY21 trading update
14th Jul 20218:27 amRNSSeeing Machines moves to SETS trading platform
7th Jul 20217:00 amRNSAgreement with Airservices Australia
5th Jul 202111:58 amRNSIssue of Shares and Total Voting Rights
30th Jun 20217:00 amRNSDirector/PDMR Shareholding
28th Jun 20212:42 pmRNSDirector/PDMR Shareholding
23rd Jun 20212:05 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.